I-01/23

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameI-01/23
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesD'Or Institute For Research And Education
China Registration ClassN/A

Develop Information

Active CompaniesD'Or Institute For Research And Education
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse ReactionsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A